Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
- DOI
- 10.1016/j.urolonc.2024.12.264
- Published
- 2025 May
- Container
- Urologic oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.urolonc.2024.12.264,
title = {Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.},
author = {Daneshmand S and Kamat AM and Shore ND and Meeks JJ and Galsky MD and Jacob JM and van der Heijden MS and Williams SB and Powles T and Chang SS and Catto JWF and Psutka SP and Guerrero-Ramos F and Xylinas E and Miyake M and Simone G and Daniel K and Sweiti H and Cutie C and Necchi A},
year = {2025},
journal = {Urologic oncology},
doi = {10.1016/j.urolonc.2024.12.264},
url = {https://doi.org/10.1016/j.urolonc.2024.12.264}
}RIS
TY - JOUR TI - Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer. AU - Daneshmand S AU - Kamat AM AU - Shore ND AU - Meeks JJ AU - Galsky MD AU - Jacob JM AU - van der Heijden MS AU - Williams SB AU - Powles T AU - Chang SS AU - Catto JWF AU - Psutka SP AU - Guerrero-Ramos F AU - Xylinas E AU - Miyake M AU - Simone G AU - Daniel K AU - Sweiti H AU - Cutie C AU - Necchi A PY - 2025 JO - Urologic oncology DO - 10.1016/j.urolonc.2024.12.264 UR - https://doi.org/10.1016/j.urolonc.2024.12.264 ER -
APA
S, D., AM, K., ND, S., JJ, M., MD, G., JM, J., MS, V. D. H., SB, W., T, P., SS, C., JWF, C., SP, P., F, G., E, X., M, M., G, S., K, D., H, S., C, C., & A, N. (2025). Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2024.12.264
Source records
- pubmed · retrieved 2026-09-26T16:14:35.657Z
- europe-pmc · retrieved 2026-09-26T16:14:35.676Z